Heidelberg Pharma
HPHA.DE
#8850
Rank
A$0.16 B
Marketcap
$3.64
Share price
-3.96%
Change (1 day)
-40.57%
Change (1 year)

Earnings for Heidelberg Pharma (HPHA.DE)

Earnings in 2024 (TTM): -A$30.99 Million

According to Heidelberg Pharma's latest financial reports the company's current earnings are A$9.24 Million. In 2023 the company made an earning of -A$33.76 Million a decrease over its 2022 earnings that were of -A$28.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Heidelberg Pharma from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$30.99 Million-8.21%
2023 -A$33.76 Million17.35%
2022 -A$28.77 Million-40.85%
2021 -A$48.64 Million43.68%
2020 -A$33.85 Million82.84%
2019 -A$18.52 Million-15.34%
2018 -A$21.87 Million9.14%
2017 -A$20.04 Million66.67%
2016 -A$12.03 Million-4.64%
2015 -A$12.61 Million-29.24%
2014 -A$17.82 Million48.61%
2013 -A$11.99 Million-42.35%
2012 -A$20.8 Million-30.97%
2011 -A$30.13 Million-36.95%
2010 -A$47.79 Million73.04%
2009 -A$27.62 Million